Hypoxia-inducible factor-1α (HIF-1α) is known to govern the response of cells to hypoxia and has been found to be highly active in ESCC, leading to a poor prognosis, spread, invasion, and resistance to therapy [23–26]. Here, HIF1A is linked to esophageal squamous cell carcinoma.